SCHEMBL20693294

SCHEMBL20693294

CCOc1cc(C(=O)OC)cc(-c2cc(C(=O)OC)cc(OC)c2OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.51
▸ NCOA1 Q15788 1/20 0.50
▸ NCOA3 Q9Y6Q9 1/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ TSHR P16473 4/20 0.48
▸ MAPT P10636 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ BPTF Q12830 1/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ CYP3A4 P08684 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ CREBBP Q92793 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3576601 0.89 LMNA (0.57) LMNANCOA1NCOA3KMT2AKDM4E
SCHEMBL17655659 0.89 TPMT (0.53) LMNAKMT2AKDM4EMEN1ALDH1A1
SCHEMBL8639986 0.85 BPTF (0.56) KMT2AKDM4EMEN1ALDH1A1TSHR
SCHEMBL28030473 0.84 TSHR (0.66) LMNAKMT2AMEN1ALDH1A1TSHR
SCHEMBL24161921 0.83 TPMT (0.60) LMNAKMT2AKDM4EMEN1ALDH1A1
SCHEMBL19272078 0.83 LMNA (0.53) LMNAKMT2AKDM4EMEN1ALDH1A1
SCHEMBL19351166 0.83 HSD17B2 (0.58) KMT2AKDM4EMEN1ALDH1A1TSHR
SCHEMBL20693295 0.82 TSHR (0.48) LMNAKMT2AKDM4EALDH1A1TSHR
SCHEMBL24161920 0.81 CYP3A4 (0.47) KMT2AKDM4EMEN1ALDH1A1TSHR
Methyl Syringate SCHEMBL211747 0.80 MEN1 (0.61) KMT2AKDM4EMEN1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190032098-A1 PROCESS FOR PREPARING BIPHENYL COMPOUNDS UNIV BORDEAUX (FR) 2019-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190032098-A1 PROCESS FOR PREPARING BIPHENYL COMPOUNDS CYP1B1, CYP1A1, CYP1A2 LMNA 1727/4885NCOA1 2419/4885NCOA3 3113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback